Medpace Holdings Inc vs Direxion Daily Semiconductor Bear 3X Shares — how do they compare? Medpace Holdings Inc trades at $533.71 (market cap $15.08B), while Direxion Daily Semiconductor Bear 3X Shares trades at $44.79. Which is the better fit depends on your goals.
| MEDP | SOXS | |
|---|---|---|
Market Cap | $15.08B | — |
Sector | Technology | Leveraged / Inverse |
52-Week High | $620.59 | $1.61K |
52-Week Low | $308.88 | $32.50 |
Enterprise Value | $14.55B | — |
Signals from Pluang's Aura AI — not financial advice
MEDP trades at $527.93, down 1.82% today, with a bullish technical outlook supported by moving averages. The company demonstrates strong profitability with 17.19% net margins and 77.25% ROE, though valuation ratios appear elevated with a P/E of 33.83. Recent earnings have consistently beaten expectations, and cash flow is projected to improve significantly in 2026. However, the stock faces headwinds from ongoing class action lawsuits and mixed analyst sentiment with 73.69% hold ratings.
MEDP presents a mixed investment case with strong fundamental performance offset by legal overhangs and premium valuation. The company's consistent earnings beats and projected cash flow improvement support upside potential, but investors should weigh the legal risks and cautious analyst stance against the robust operational metrics.
SOXS, the Direxion Daily Semiconductor Bear 3X ETF, trades at $53.99, down 1.64% today, reflecting its inverse leveraged exposure to semiconductor stocks. Technical indicators show a bullish moving average signal but bearish oscillators with RSI levels above 96 suggesting extreme overbought conditions. Recent news highlights SOXS surging during semiconductor sell-offs, with a 1:10 stock split scheduled for July 26, 2026. The fund is designed for short-term tactical trades amid sector volatility.
The outlook for SOXS remains highly speculative, offering potential gains during semiconductor downturns but carrying significant decay and volatility risks. Investors should be cautious as the ETF is not suitable for long-term holdings due to its daily reset structure and inverse leverage, which can lead to substantial losses in rising markets.
Trailing returns across standard periods
Medpace Holdings, Inc. is a full-service clinical contract research organization (CRO) that provides comprehensive and scientifically-driven clinical development services to the biotechnology, pharmaceutical, and medical device industries. The company specializes in conducting global clinical trials for new drug and medical device approvals. Medpace's model emphasizes therapeutic expertise and a highly integrated approach to accelerate the clinical development process for its clients.
Read more on MEDP →SOXS is a leveraged ETF that seeks daily investment results corresponding to 300% of the inverse (opposite) of the daily performance of the ICE Semiconductor Index. It is designed as a tactical tool for experienced traders to take a bearish (short) position on the semiconductor sector. Due to the effects of compounding and leverage, SOXS is intended to be held for a single day and is not suitable for long-term investment.
Read more on SOXS →